1. |
Letters to the Editor… |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 4-11
Preview
|
PDF (10296KB)
|
|
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904924
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
2. |
From the Editor… |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 5-5
MortensonLee E.,
Preview
|
PDF (9702KB)
|
|
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904925
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
3. |
The President's Corner… |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 9-9
KingDavid K.,
Preview
|
PDF (172KB)
|
|
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904926
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
4. |
In the News: Legislation/Regulation… |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 10-11
Preview
|
PDF (224KB)
|
|
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904927
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
5. |
Pharmaceutical Reimbursement a National Health Policy Issue? it May Be the Only Solution to Continuing Payment Problems |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 12-23
MannistoMarilyn M.,
Preview
|
PDF (16869KB)
|
|
摘要:
Summary:Solutions to the pharmaceutical payment issues raised in the first part of this two-part article cannot be left unresolved. Numerous options are presented in this article, some of which show little promise for inducing significant change, but others may be the types of approaches that eventually will prove effective in bringing about uniform, adequate payment for state-of-the-art cancer treatment.
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904928
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
6. |
FDA's Treatment IND: Good News or Bad News for Cancer Care? |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 24-27
MannistoMarilyn M.,
Preview
|
PDF (5954KB)
|
|
摘要:
Summary:Many providers believe the FDA's new“fast track”approval process for experimental drugs—treatment IND—is a step in the right direction, but participants at a recent AMA-FDA conference raised serious questions about such issues as payment, access, liability, and the effect on clinical trials.
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904929
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
7. |
A Commonsense Approach to Maximizing Office Reimbursement |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 29-30
BullionJames,
Preview
|
PDF (280KB)
|
|
摘要:
Summary:James Bullion and Cavan Redmond, both of whom have extensive experience with insurance claims processing systems, have some simple but effective tips to help office-based physicians and their staffs to maximize reimbursement.
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904930
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
8. |
Other Areas That Merit Review: Forms, Denials, and Appeals |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 30-31
RedmondCavan,
Preview
|
PDF (1494KB)
|
|
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904931
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
9. |
Audit Indicates Many Uses of Combination Therapy are Unlabeled |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 33-33
MortensonLee E.,
Preview
|
PDF (366KB)
|
|
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904932
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|
10. |
Annual Meeting Highlights |
|
The Journal of Cancer Program Management,
Volume 3,
Issue 2,
1988,
Page 35-37
Preview
|
PDF (1501KB)
|
|
摘要:
Summary:The ACCC's Annual Meeting, held March 16-19 in Washington, DC, focused on such issues as measuring quality of care, pharmaceutical reimbursement, and membership's ongoing involvement in governmental affairs.
ISSN:0898-6053
DOI:10.1080/08986053.1988.11904933
出版商:Taylor&Francis
年代:1988
数据来源: Taylor
|